F2R and gastric cancer: The statistical analysis of the ratios of tumor weight over total situs weight proved that PAR1 activated gastric cancer cell by TFLLR-NH2 resulted in a significant increase of tumor burden (MKN45/PAR1 and MKN74 cells treated by TFLLR-NH2 versus control, P < 0.05; Figure 2D).